XBJI is used for syndrome of blood-stasis and toxins in the progressive stage of COVID-19 (critical case). Indicative symptoms are fever, dyspnea and tachypnea, palpitations, and dysphoria. It could also be used for treatment of infection-induced systemic inflammatory response syndrome and multiple-organ dysfunction syndrome in the stage of impaired organ function.